Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Presentation of Wouter De Maeseneire

722 views

Published on

Event MFM
Meet the Industry: Pharma

Published in: Business
  • Be the first to comment

  • Be the first to like this

Presentation of Wouter De Maeseneire

  1. 1. SOME PHARMA FINANCIALS PROF. DR. WOUTER DE MAESENEIRE
  2. 2. DISCLAIMER  I am not a pharma/healthcare expert  But I did quite some work for student in- company projects or customized trainings for  Pfizer, J&J (Janssen), Arseus, Capsugel, UCB, Boehringher-Inghelheim,…  IRC MFM last year: UCB  I wrote a case on BigPharma vs Small Biotech FSA  I’ll give a broad overview of some of the issues
  3. 3. © Vlerick Business School3
  4. 4. © Vlerick Business School PROFIT AND LOSS ACCOUNT/INCOME STATEMENT 4
  5. 5. © Vlerick Business School APPLE: PROFIT AND LOSS ACCOUNT (P&L) 5
  6. 6. © Vlerick Business School DO YOU KNOW… 6
  7. 7. © Vlerick Business School AN UNFORESEEN OUTCOME… 7
  8. 8. © Vlerick Business School LIPITOR  Peak sales  Cumulative sales (1996-2012) 8
  9. 9. © Vlerick Business School PFIZER: PROFIT AND LOSS ACCOUNT (P&L) 9
  10. 10. 12
  11. 11. 13
  12. 12. 14
  13. 13. 15
  14. 14. 16
  15. 15. 17
  16. 16. 18
  17. 17. © Vlerick Business School GALAPAGOS 19
  18. 18. © Vlerick Business School GALAPAGOS: P&L 20
  19. 19. © Vlerick Business School21
  20. 20. © Vlerick Business School GALAPAGOS: ASSETS 22
  21. 21. © Vlerick Business School GALAPAGOS: EQUITY AND LIABILITIES 23
  22. 22. © Vlerick Business School GALAPAGOS: CASH FLOW STATEMENT 24
  23. 23. © Vlerick Business School A LOT OF BIG PHARMA & SMALL BIOTECH DEALS  M&A, alliances, milestone payments, co- development, licencsing out,…  Clear complementarities 25

×